The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Astellas Pharma; Boston Biomedical
Research Funding - Abbvie; Agios; Daiichi Sankyo; Millennium
Timing of response to venetoclax combination treatment in older patients with acute myeloid leukemia.
 
Brian Andrew Jonas
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlycoMimetics; Jazz Pharmaceuticals; Pharmacyclics; Tolero Pharmaceuticals; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Accelerated Medical Diagnostics (Inst); Arog (Inst); Celgene (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); Hanmi (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); LP Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Sigma-Tau (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen
 
Courtney Denton Dinardo
Leadership - Notable Labs
Honoraria - Abbvie; Agios; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; MedImmune; Syros Pharmaceuticals
Consulting or Advisory Role - Abbvie; Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Keith Pratz
No Relationships to Disclose
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Celgene; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Amgen; Celgene; Novartis
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Servier
 
Wan-Jen Hong
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Brenda Chyla
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Yinghui Duan
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jalaja Potluri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Michael Werner
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Daniel Aaron Pollyea
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Forty Seven; Gilead Sciences; Glycomimetics; Janssen; Pfizer; Takeda
Research Funding - Abbvie (Inst); Pfizer (Inst)